P23T (p.Pro23Thr) variant of CEBPA (P49715)
P23T (p.Pro23Thr) in CEBPA (P49715) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Hereditary cancer-predisposing syndrome; Inborn genetic diseases; Acute myeloid. The available variant effect predictions contribute to a CATVariant prioritization score of 0.24 / 1. The record also includes population frequency data, published literature, and structural context.
P23T (p.Pro23Thr) variant details
- p.Pro23Thr
- rs1478319097
- ClinGen CA405275748
- ClinVar RCV001320448
- ClinVar RCV002256742
- Uncertain significance
- Hereditary cancer-predisposing syndrome; Inborn genetic diseases; Acute myeloid
- Missense
- Variant Prioritization Score for Impact Estimate 0.238
- REVEL 0.03
- MetaLR 0.04
- MetaSVM -1.00
- CADD 22.40
- PolyPhen-2 0.00
- SIFT 0.16
- ClinVar: Uncertain significance (Hereditary cancer-predisposing syndrome; Inborn genetic diseases)
- EBI: Variant of uncertain significance
- UniProt: Uncertain significance
- Most common in the Non-Finnish European population (allele frequency 3.1e-06)
- Structural context available
- Cited in: CEBPA-Associated Familial Acute Myeloid Leukemia (AML). (PMID 20963938)
- Cited in: NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology. (PMID 22138009)